Spain offers a comprehensive range of Parkinson's disease treatments, including pharmacological therapy, deep brain stimulation (DBS), and non-invasive MR-guided focused ultrasound (MRgFUS). Patients access specialized care at JCI-accredited centers in Barcelona and Madrid, where neurologists utilize 3T intraoperative MRI and robotic systems for neurosurgical precision.
- Deep brain stimulation: Surgical electrodes target the subthalamic nucleus to control motor symptoms effectively.
- MR-guided focused ultrasound: This non-invasive technique uses ultrasound waves to treat tremor-dominant Parkinson's cases.
- Continuous dopaminergic stimulation: Advanced infusion therapies like Duodopa and Apomorphine pumps manage motor fluctuations.
- Pharmacological first-line care: Approximately 90% of patients receive Levodopa alongside MAO-B inhibitors or agonists.
Bookimed Expert Insight: Clinical volume is a major quality indicator in Spain. For instance, Dr. Bartolome Oliver at Centro Médico Teknon has performed over 1,100 DBS procedures. Choosing a high-volume specialist often translates to better surgical precision. Some Madrid clinics also offer free treatment through neurodegenerative disorder clinical trials, which is a rare but valuable opportunity for eligible international patients.
Patient Consensus: Patients note that starting with a detailed symptom log helps speed up the evaluation process in Spain. Many suggest joining local support groups to navigate the choice between private clinics and the public healthcare system.